Why the study?
Is the MOMO cobalt-chromium carbon-coated stent safe and feasible in patients with single focal de novo lesions presenting with stable and unstable CAD?
Is the MOMO cobalt-chromium carbon-coated stent safe and feasible in patients with single focal de novo lesions presenting with stable and unstable CAD?
The MOMO cobalt-chromium carbon-coated stent shows initial proof of concept for safety and feasibility in patients with CAD.
Hypothesis-generating for novel stent coatings; leaves open randomized trials before any clinical consideration.
This first-in-man experience demonstrates proof of concept of the safety and feasibility of the MOMO cobalt-chromium carbon-coated stent for patients with single focal de novo lesions presenting with stable and unstable CAD.
No takes yet. Share an insight, caveat, or question.
Kesavan et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: